Trilogy Capital’s Vanguard High Dividend Yield ETF VYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Buy
14,581
+2,981
+26% +$466K 0.09% 153
2026
Q1
$1.72M Buy
11,600
+420
+4% +$63.1K 0.08% 160
2025
Q4
$1.6M Sell
11,180
-889
-7% -$126K 0.07% 161
2025
Q3
$1.7M Buy
12,069
+220
+2% +$30.2K 0.08% 154
2025
Q2
$1.58M Buy
11,849
+243
+2% +$30.8K 0.08% 153
2025
Q1
$1.5M Hold
11,606
0.08% 149
2024
Q4
$1.48M Sell
11,606
-31
-0.3% -$4.04K 0.08% 161
2024
Q3
$1.49M Hold
11,637
0.08% 161
2024
Q2
$1.38M Buy
+11,637
New +$1.38M 0.07% 150
2021
Q2
Sell
-7,626
Closed -$771K 189
2021
Q1
$771K Buy
7,626
+1,350
+22% +$130K 0.06% 111
2020
Q4
$574K Buy
6,276
+950
+18% +$82.5K 0.05% 109
2020
Q3
$431K Buy
5,326
+1,191
+29% +$97.5K 0.04% 111
2020
Q2
$335K Buy
+4,135
New +$321K 0.03% 102
2018
Q4
Sell
-455
Closed -$40K 567
2018
Q3
$40K Hold
455
﹤0.01% 215
2018
Q2
$38K Buy
455
+3
+0.7% +$251 0.01% 201
2018
Q1
$37K Buy
+452
New +$38.9K 0.01% 182

Other funds holding VYM

Trilogy Capital's VYM Position: Q2 2026 in Review

Trilogy Capital increased its Vanguard High Dividend Yield ETF (VYM) stake by 26% in Q2 2026, buying an estimated $466K and bringing the position to 14,581 shares worth $2.3M. The position accounts for 0.09% of the portfolio, ranked #153.

Trilogy Capital first reported a position in VYM in Q1 2018 and has held it in 16 quarters since. 404 funds tracked by Wall St. Rank hold VYM as of Q2 2026.

  • Trilogy Capital held 14,581 shares of Vanguard High Dividend Yield ETF worth $2.3M as of Q2 2026.
  • Trilogy Capital bought 2,981 Vanguard High Dividend Yield ETF shares in Q2 2026, an estimated $466K.
  • Vanguard High Dividend Yield ETF made up 0.09% of Trilogy Capital's portfolio in Q2 2026, its #153 holding.
  • Trilogy Capital first reported a position in Vanguard High Dividend Yield ETF in Q1 2018 and has held it in 16 quarters since.
  • 404 funds tracked by Wall St. Rank held Vanguard High Dividend Yield ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.